List of works - Vera Magistroni

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants

scientific article published on 15 December 2008

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene

scientific article published on 16 July 2015

CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data

scientific article

Colorectal Tumors Are Effectively Eradicated by Combined Inhibition of -Catenin, KRAS, and the Oncogenic Transcription Factor ITF2

scientific article published on 07 September 2010

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

scientific article published on 28 February 2019

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.

scientific article published on June 2015

ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells

scientific article

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

scientific article published on 20 July 2010

Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.

scientific article published on May 2013

FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery

scientific article

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

scientific article

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells

scientific article

RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients

scholarly article by Rocco Piazza et al published 17 November 2015 in American Journal of Hematology

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.

scientific article published on 24 October 2014

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

scientific article

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.

scientific article

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

scientific article published on January 2017

The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years.

scientific article

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors.

scientific article

Valproic acid enhances bosutinib cytotoxicity in colon cancer cells

scientific article

List of works by Vera Magistroni

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene

CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data

Colorectal Tumors Are Effectively Eradicated by Combined Inhibition of -Catenin, KRAS, and the Oncogenic Transcription Factor ITF2

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.

ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.

FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells

RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years.

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors.

Valproic acid enhances bosutinib cytotoxicity in colon cancer cells